SD increases AF susceptibility by modulating the autonomic nervous system toward sympathetic predominance, resulting in heart failure with SAN dysfunction, suppressed GRK2 expression, and enhanced PV and LA arrhythmogenesis. The gene discussed is GRK2; the disease is heart failure.